Top

Alán Aspuru-Guzik

Alán Aspuru-Guzik honoured with Heinrich Emanuel Merck Award for Computational Sciences

The Heinrich Emanuel Merck Award was awarded to Alán Aspuru-Guzik on June 28, 2025, recognizing groundbreaking innovation in computational sciences.

Alán Aspuru-Guzik talks about chemistry and data technology in Lindau at the HEM Awards presentation.

Alán Aspuru-Guzik talks about the interplay of chemistry and information in Lindau. (photo: supplied)

According to a press release from the science and technology company Merck, the award honours “extraordinary contributions in the integration of advanced computational methods with scientific discovery.” It celebrates current innovators in tribute to namesake Heinrich Emanuel Merck’s legacy of scientific curiosity and innovation.

Aspuru-Guzik is jointly appointed as Professor at the Department of Chemistry and the Department of Computer Science. Receiving the prize in Lindau, Switzerland, he said, “My research interests are in areas that are poised to disrupt the chemical sciences. We have pioneered algorithms for near-term quantum computers, artificial intelligence and robotics for new materials. Recently, we have focused strongly on AI agents that do science.”

“Receiving the Heinrich Emanuel Merck Award is a testament to the exceptionally talented, motivated and collaborative Matter Lab research group that we have assembled at the University of Toronto.”

Laura Matz, chief science and technology officer at Merck, also spoke of cooperation and collaboration, “Today we celebrate not just individual achievement, but a vision for a future where scientific breakthroughs transform lives and create new pathways for innovation.”

Aspuru-Guzik was lauded at the event as “a leading researcher, at the intersection of quantum information, quantum computing, artificial intelligence, automation and chemistry, dedicated to accelerating scientific discovery and finding novel materials.”

“His work includes utilizing generative machine learning to optimize wave functions for quantum simulations,” read the press release. “Additionally, he has made significant contributions in creating self-driving laboratories (SDLs) that leverage Al and automation.”

The Matter Lab’s innovative work, it noted, includes integrating quantum components into drug discovery pipelines, showcasing the potential of hybrid quantum-classical systems in generating viable drug candidates.

Aspuru-Guzik delivered a talk at the Lindau award ceremony, entitled, “The materials for tomorrow, today.” In it, he argued that the interplay between chemistry and information started four billion years ago and continues evolving thanks to the availability of AI algorithms. "Eventually they become autonomous research scientists."

— Original story by Alyx Dellamonica for the Department of Chemistry

Maclean’s ‘The Power List: AI’ recognizes U of T CS faculty and alumni

Maclean’s ‘The Power List: AI’ recognizes U of T CS faculty and alumni

U of T CS faculty and alumni are among a group of individuals recognized on the 2024 Power List by Maclean’s magazine.

Acceleration Consortium seed grants support new research into self-driving labs technology

Acceleration Consortium seed grants support new research into self-driving labs technology

Computer scientists Nandita Vijaykumar and Joseph Jay Williams are among 12 recipients of grants from the Acceleration Consortium. 

U of T receives $200-million grant to support Acceleration Consortium's ‘self-driving labs’ research

U of T receives $200-million grant to support Acceleration Consortium's ‘self-driving labs’ research

Led by Professor Alán Aspuru-Guzik, the consortium works to develop “self-driving labs” that combine artificial intelligence, robotics and advanced computing to discover new materials and molecules in a fraction of the usual time and cost.  

University of Toronto scientists use machine learning to fast-track drug formulation development

University of Toronto scientists use machine learning to fast-track drug formulation development

A new study co-led by Professor Alán Aspuru-Guzik demonstrates the potential for machine learning to accelerate the development of innovative drug delivery technologies.